We serve 2-morpholin-4-ylethanamine CAS:2038-03-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-morpholin-4-ylethanamine
CAS.NO:2038-03-1
Molecular Formula: ：C6H14N2O
Molecular Weight: 130.18800
Synonyms:
2-(morpholin-4-yl)-ethyl amine
2-Morpholinoethanamine
N-2-Aminoethylmorfolin [Czech]
4-(2-Aminoethyl)Morpholine
N-Aminoethylmorpholine
N-(2-aminoethyl)-morpholine
2-(N-morpholino)ethylamine
4-Morpholineethanamine
4-(2-aminoethyl)-morpholine
2-Morpholinoethylamine
Morpholine,4-(2-aminoethyl)
Physical and Chemical Properties:
Density: 0.992 g / mL at 25 ° C (lit.)
Boiling point: 205 ° C (lit.)
Melting point: 24 ° C
Flash point: 347 ° F
Refractive index: n20 / D 1.476 (lit.)
Specification:
Appearance:Colorless Liquid
Purity:≥98.0%
Moisture Content: 0.25%
Impurity: 0.3%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 4-(2-Aminoethyl)morpholine is used as a reagent in the synthesis of novel quinoxaline-5-carboxamide derivatives which have antibacterial activity. Also used as a reagent in the synthesis of pyrazol-4-ylpyrimidine derivatives as potential ROS1 kinase inhibitors.
Contact us for information like 2-morpholin-4-ylethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Morpholine,4-(2-aminoethyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-morpholin-4-ylethanamine Use and application,4-(2-Aminoethyl)Morpholine technical grade,usp/ep/jp grade.
Related News: China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.4-[(6-oxo-1H-pyrimidin-2-yl)amino]benzonitrile manufacturer The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.2-(4-chlorophenyl)-1-methyl-5-(trifluoromethyl)pyrrole-3-carbonitrile supplier The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.N-[4-(4-Fluorophenyl)-5-formyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl-methanesulfonamide vendor The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China.
